0001209191-23-037914.txt : 20230616 0001209191-23-037914.hdr.sgml : 20230616 20230616163126 ACCESSION NUMBER: 0001209191-23-037914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PHILIPS CRAIG W. CENTRAL INDEX KEY: 0001441383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 231021689 MAIL ADDRESS: STREET 1: C/O KINETA, INC. STREET 2: 219 TERRY AVE. N., SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER NAME: FORMER CONFORMED NAME: PHILIPS CRAIG DATE OF NAME CHANGE: 20080729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-14 0 0001445283 KINETA, INC./DE KA 0001441383 PHILIPS CRAIG W. C/O KINETA, INC. 219 TERRY AVE. N., SUITE 300 SEATTLE WA 98109 0 1 0 0 President 0 Common Stock 2023-06-14 4 M 0 1382 0.14 A 34654 I By Whetstone Ventures, LLC Common Stock 2023-06-14 4 F 0 12666 2.82 D 54311 D Warrats (Right to Buy) 0.14 2023-06-14 4 M 0 1382 0.00 D 2025-12-02 Common Stock 1382 0 I By Whetstone Ventures, LLC The Reporting Person is a member manager of Whetstone Ventures, LLC ("Whetstone") and shares voting and dispositive power over the shares held by Whetstone. Exempt transaction pursuant to Rule 16b-3(e) for the withholding of shares of the Issuer's Common Stock by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units. The warrants are immediately exercisable in full. /s/ Pauline Kenny, as Attorney-in-Fact 2023-06-16